BridgeMD
New treatment option for Mindfulness
Official title Mindful-Breath for People With COPD
ClinicalTrials.gov ID: NCT07195838
What this study is testing
- What it's testing
- Individuals living with chronic obstructive pulmonary disease (COPD) often suffer from stress and behavioral risks such as physical inactivity. In an attempt to promote healthy behaviors and overall wellbeing among this particular population, this study aims to develop and evaluate a personalized Mindful-Breath intervention combining telehealth technology and mindfulness for COPD patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Age: 50-80 years
- Sex: Male or female
- Education level: Primary or above
- Diagnosis: COPD (Baseline FEV1 \<80% and FEV1/FVC \<70% of predicted normal values)
- Severity of COPD: Stage I to IV
You likely can't join if
- Engaging in \>60 minutes/week of moderate PA based on American Lung Association guidelines
- Recent or ongoing receipt of other pharmacological/behavioral trials within the past 3 months
- Contraindications or severe comorbidities that may limit full participation (mental diseases, deafness, limb activity disorder, coronary heart...
- Co-existing respiratory diseases (Asthma/interstitial lung disease/bronchiectasis) or active malignancies
- Very severe COPD requiring long-term oxygen therapy or home non-invasive ventilation
See the full eligibility criteria
- Age: 50-80 years
- Sex: Male or female
- Education level: Primary or above
- Diagnosis: COPD (Baseline FEV1 \<80% and FEV1/FVC \<70% of predicted normal values)
- Severity of COPD: Stage I to IV
- Group of COPD: Group B, or E, based on 2024 GOLD guideline (36)
- Clinical stability: No acute exacerbation in the past 4 weeks. Patients with recent acute exacerbation in the past 4 weeks will be screened again in subsequent follow-up.
- Moderate stress: PSS score ≥14 (28)
- Access to a mobile device (e.g., a smartphone, tablet, or laptop) with internet connectivity
- Ability to read, communicate, and provide written consent in Chinese.
- Engaging in \>60 minutes/week of moderate PA based on American Lung Association guidelines
- Recent or ongoing receipt of other pharmacological/behavioral trials within the past 3 months
- Contraindications or severe comorbidities that may limit full participation (mental diseases, deafness, limb activity disorder, coronary heart disease, arterial aneurysm, uncontrolled hypertension, pregnancy, etc)
- Co-existing respiratory diseases (Asthma/interstitial lung disease/bronchiectasis) or active malignancies
- Very severe COPD requiring long-term oxygen therapy or home non-invasive ventilation
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.